Skip to content

Appropriation of the Connected Solution Freestyle Libre® in Adult Patients With Diabetes in the Context of Therapeutic Education

Appropriation of the Connected Solution Freestyle Libre® in Adult Patients With Diabetes in the Context of Therapeutic Education

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04739124
Acronym
APPRO-FSL
Enrollment
86
Registered
2021-02-04
Start date
2021-06-10
Completion date
2023-09-06
Last updated
2023-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

Following the proposal to self-monitor by the Freestyle Libre® (FSL) connected object, in diabetic patients in the context of therapeutic education, regarding the appropriation of FSL, what works, for which patients , in what specific contexts and by what mechanisms does it govern? A multicentric observational research will be conducted with mixed method design (follow-up using patient questionnaires) and semi-structured interviews of patients and caregivers.

Interventions

The patient normally follows the education program as usual but research specific data is collected: * Biological sampling at the start and end of the education program (glycated hemoglobin). * Retrieval of usage and glycemic balance data from the Libreview online platform (at one week, one month and three months of use) * Iterative questionnaires allowing the study of factors of acceptance, appropriation and use (at the start of the study, at 4 weeks, at 12 weeks)

OTHERInterviews

Semi-structured interviews will be carried out during the visits, either face-to-face or remotely.

Sponsors

Direction Centrale du Service de Santé des Armées
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients * Have type 1 or type 2 diabetes (as included in the education program), * Be of legal age (over 18 years old), * Do not present legal protection measures due to incapacity (such as guardianship or guardianship). * Be able to read and speak French (elementary school level) * Be eligible for FSL prescription and authorize the sharing of your data in Libreview® * Be affiliated to a social security scheme * Have an email address or a phone allowing internet use * Caregivers * Be registered on the roll of his professional order * Hold the certificate of 40 hours of training in therapeutic education. * Practice therapeutic education on a regular basis

Exclusion criteria

* Patients * presenting contraindications to the use of Freestyle Libre® (known allergies to adhesive products, coagulation disorders, not treated with insulin therapy or with less than 3 insulin injections per day or continuously, not requiring glycemic monitoring or less than 3 times a day) * Patient refusing to follow the education program, * Minors, patients under administrative or judicial supervision) * Pregnant women, * Patients who cannot be contacted in an emergency, * Persons in a position to give their consent but with an inability to read / write the French language. * Patients who do not have an email address or a phone allowing internet use. * Caregivers * Failure to register with the professional order (except those of the Army Health Service who are exempt) * Non-possession of the 40-hour therapeutic education training certificate. * Not practicing FSL education

Design outcomes

Primary

MeasureTime frameDescription
Correlation between appropriation factors, intention to use, Freestyle Libre use and glycemic control3 monthslongitudinal multifactor analysis by structural equation modeling of the research model created specifically

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026